Santos Carlos E — SEC insider filings
SEC reporting owner CIK 2097065. 1 insider filing on record with FilingPulse; latest filed 2026-09-23.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2026-09-23 to 2026-09-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 5,430 shares, $49,630 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: sale of 5,430 shares @ $9.14 ($49,630) in Legend Biotech Corp, filed 2026-09-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Legend Biotech Corp (LEGN) | Chief Financial Officer | 1 | — | 1 leg · 5,430 sh · $49,630 | 1 |
Insider filings — Santos Carlos E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-23 | 4 | Legend Biotech Corp (LEGN) | Grant/award (A): 19,676 @ $0 · Sale (S): 5,430 @ $9.14 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2023-11-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2097065 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →